News

Belzutifan is a hypoxia-inducible factor-2α inhibitor that is US FDA approved for the treatment of VHL disease-associated renal cell carcinoma (RCC), CNS hemangioblastomas, or pancreatic ...
Investigators analyzed blood samples from patients on dialysis to study uremic toxins in association with renal anemia pathogenesis.
(HealthDay News) — The Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet with lower sodium is tied to clinically meaningful blood pressure reduction in people with diabetes, according ...
(HealthDay News) — Neither delivery of electronic nudge letters nor letters to general practice increase uptake of guideline-directed medical therapy (GDMT) among patients with chronic kidney disease ...
The first trial of adjuvant platinum-based chemotherapy plus paclitaxel in patients with high-risk penile cancer provided some insights.
Unvaccinated patients had higher rate of continuous renal replacement therapy during hospitalization and higher rate of being discharged on RRT.
Although this was a negative study, I think the data shown here contribute to our knowledge of IO treatments in urothelial cancer,” said Michiel Van der Heijden, MD, PhD.
(HealthDay News) — Cannabis use is associated with major adverse cardiovascular events (MACE), according to a systematic review based on real-world data published online June 17 in Heart.
EAU guidelines offer updated guidance on diagnosis, treatment, & follow-up of patients with metastatic & muscle-invasive ...
Steroidal mineralocorticoid receptor antagonists (MRAs) may not lower risk for all-cause or cardiovascular (CV) mortality among patients receiving maintenance dialysis, according to a meta-analysis ...
More than half (57.4%) of respondents reported ever using cannabis through smoking, vaping, dabbing, or ingesting edibles. Of respondents with data evaluable on forms of lifetime cannabis use, 28. ...